Written by Linc Bedrosian
Genetically modified Atlantic salmon — known by critics as "Frankenfish" — may soon be available in your local grocer's seafood aisle. The Food and Drug Administration has given initial approval to the biotech developers of the salmon, clearing the last big hurdle before consumers can purchase the fish.
But consumers won't know if the salmon they're buying is genetically engineered or not — U.S. regulations don't require food made from a genetically modified organism (GMO) to be labeled. That fact, plus the impact the engineered salmon could have on wild salmon stocks, human health and the fishing industry, has critics raising a stink with the FDA, according to the Huffington Post.
The Atlantic salmon developed by Massachusetts-based AquaBounty was genetically modified using DNA material from a Chinook salmon and an eel-like species called an ocean pout. These genes cause the fish to grow twice as fast as wild salmon, according to the British newspaper The Telegraph, making production of the fish far more cost effective.
Read the full story at LiveScience>>
NMFS recently released a draft action plan for fish discard and release mortality science, creating a list of actions that they hope can better inform fisheries.
We know that fishermen have to deal with bycatch by discarding or releasing unwanted catch overboard, but there is a data gap regarding how those fish survive.Read more...
A new study has identified a set of features common to all ocean ecosystems that provide a visual diagnosis of the health of the underwater environment coastal communities rely on.
Together, the features detail cumulative effects of threats -- such as overfishing, pollution, and invasive species, allowing responders to act faster to increase ocean resiliency and sustainability.Read more...